{
     "PMID": "20443629",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20100622",
     "LR": "20141120",
     "IS": "1520-4804 (Electronic) 0022-2623 (Linking)",
     "VI": "53",
     "IP": "10",
     "DP": "2010 May 27",
     "TI": "The synthesis and biological evaluation of quinolyl-piperazinyl piperidines as potent serotonin 5-HT1A antagonists.",
     "PG": "4066-84",
     "LID": "10.1021/jm1000908 [doi]",
     "AB": "As part of an effort to identify 5-HT(1A) antagonists that did not possess typical arylalkylamine or keto/amido-alkyl aryl piperazine scaffolds, prototype compound 10a was identified from earlier work in a combined 5-HT(1A) antagonist/SSRI program. This quinolyl-piperazinyl piperidine analogue displayed potent, selective 5-HT(1A) antagonism but suffered from poor oxidative metabolic stability, resulting in low exposure following oral administration. SAR studies, driven primarily by in vitro liver microsomal stability assessment, identified compound 10b, which displayed improved oral bioavailability and lower intrinsic clearance. Further changes to the scaffold (e.g., 10r) resulted in a loss in potency. Compound 10b displayed cognitive enhancing effects in a number of animal models of learning and memory, enhanced the antidepressant-like effects of the SSRI fluoxetine, and reversed the sexual dysfunction induced by chronic fluoxetine treatment.",
     "FAU": [
          "Childers, Wayne E Jr",
          "Havran, Lisa M",
          "Asselin, Magda",
          "Bicksler, James J",
          "Chong, Dan C",
          "Grosu, George T",
          "Shen, Zhongqi",
          "Abou-Gharbia, Magid A",
          "Bach, Alvin C 3rd",
          "Harrison, Boyd L",
          "Kagan, Natasha",
          "Kleintop, Teresa",
          "Magolda, Ronald",
          "Marathias, Vasilios",
          "Robichaud, Albert J",
          "Sabb, Annmarie L",
          "Zhang, Mei-Yi",
          "Andree, Terrance H",
          "Aschmies, Susan H",
          "Beyer, Chad",
          "Comery, Thomas A",
          "Day, Mark",
          "Grauer, Steven M",
          "Hughes, Zoe A",
          "Rosenzweig-Lipson, Sharon",
          "Platt, Brian",
          "Pulicicchio, Claudine",
          "Smith, Deborah E",
          "Sukoff-Rizzo, Stacy J",
          "Sullivan, Kelly M",
          "Adedoyin, Adedayo",
          "Huselton, Christine",
          "Hirst, Warren D"
     ],
     "AU": [
          "Childers WE Jr",
          "Havran LM",
          "Asselin M",
          "Bicksler JJ",
          "Chong DC",
          "Grosu GT",
          "Shen Z",
          "Abou-Gharbia MA",
          "Bach AC 3rd",
          "Harrison BL",
          "Kagan N",
          "Kleintop T",
          "Magolda R",
          "Marathias V",
          "Robichaud AJ",
          "Sabb AL",
          "Zhang MY",
          "Andree TH",
          "Aschmies SH",
          "Beyer C",
          "Comery TA",
          "Day M",
          "Grauer SM",
          "Hughes ZA",
          "Rosenzweig-Lipson S",
          "Platt B",
          "Pulicicchio C",
          "Smith DE",
          "Sukoff-Rizzo SJ",
          "Sullivan KM",
          "Adedoyin A",
          "Huselton C",
          "Hirst WD"
     ],
     "AD": "Chemical Sciences, Pfizer Global Research and Development, Princeton, New Jersey 08543-8000, USA. wchilders@yahoo.com",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "United States",
     "TA": "J Med Chem",
     "JT": "Journal of medicinal chemistry",
     "JID": "9716531",
     "RN": [
          "0",
          "(5-fluoro-8-(4-(4-(6-methoxyquinolin-8-yl)piperazin-1-yl)piperidin-1-yl)quinoline",
          ")",
          "0 (Amyloid beta-Protein Precursor)",
          "0 (Antidepressive Agents)",
          "0 (Nootropic Agents)",
          "0 (Piperazines)",
          "0 (Piperidines)",
          "0 (Quinolines)",
          "0 (Serotonin 5-HT1 Receptor Antagonists)",
          "01K63SUP8D (Fluoxetine)",
          "333DO1RDJY (Serotonin)",
          "N9YNS0M02X (Acetylcholine)"
     ],
     "SB": "IM",
     "MH": [
          "Acetylcholine/metabolism",
          "Administration, Oral",
          "Amyloid beta-Protein Precursor/genetics",
          "Animals",
          "Antidepressive Agents/chemical synthesis/chemistry/pharmacology",
          "Biological Availability",
          "CHO Cells",
          "Cerebral Cortex/metabolism",
          "Cognition/drug effects",
          "Cricetinae",
          "Cricetulus",
          "Fluoxetine/pharmacology",
          "Hippocampus/metabolism",
          "In Vitro Techniques",
          "Maze Learning/drug effects",
          "Memory/drug effects",
          "Mice",
          "Mice, Transgenic",
          "Microsomes, Liver/metabolism",
          "Nootropic Agents/chemical synthesis/chemistry/pharmacology",
          "Penile Erection/drug effects",
          "Piperazines/*chemical synthesis/chemistry/pharmacology",
          "Piperidines/*chemical synthesis/chemistry/pharmacology",
          "Quinolines/*chemical synthesis/chemistry/pharmacology",
          "Rats",
          "Serotonin/metabolism",
          "*Serotonin 5-HT1 Receptor Antagonists",
          "Structure-Activity Relationship"
     ],
     "EDAT": "2010/05/07 06:00",
     "MHDA": "2010/06/23 06:00",
     "CRDT": [
          "2010/05/07 06:00"
     ],
     "PHST": [
          "2010/05/07 06:00 [entrez]",
          "2010/05/07 06:00 [pubmed]",
          "2010/06/23 06:00 [medline]"
     ],
     "AID": [
          "10.1021/jm1000908 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Med Chem. 2010 May 27;53(10):4066-84. doi: 10.1021/jm1000908.",
     "term": "hippocampus"
}